Epidemiology of polypharmacy among family medicine patients at hospital discharge

Journal of Primary Care and Community Health

Volumn 4, Issue 2, 2013, Pages 101-105

  Rohrer, James E ^a   Garrison, Gregory ^a   Oberhelman, Sara A ^a   Meunier, Matthew R ^a  

^a MAYO CLINIC   (United States)

Author keywords

Elderly; Hospital readmission; Managerial epidemiology; Polypharmacy; Quality indicator

Indexed keywords

AGED; ARTICLE; CHRONIC DISEASE; DEMOGRAPHY; DRUG USE; EDUCATIONAL STATUS; FEMALE; GENERAL PRACTICE; HEALTH SERVICE; HOSPITAL DISCHARGE; HOSPITAL READMISSION; HUMAN; MALE; MANAGERIAL EPIDEMIOLOGY; MARRIAGE; NONPARAMETRIC TEST; PILOT STUDY; POLYPHARMACY; QUALITY INDICATOR; RISK ASSESSMENT; STANDARD; STATISTICS; UNITED STATES; UTILIZATION REVIEW;

ELDERLY; HOSPITAL READMISSION; MANAGERIAL EPIDEMIOLOGY; POLYPHARMACY; QUALITY INDICATOR;

AGED; CHRONIC DISEASE; DRUG UTILIZATION REVIEW; EDUCATIONAL STATUS; FAMILY PRACTICE; FEMALE; HEALTH SERVICES; HUMANS; MALE; MARITAL STATUS; PATIENT DISCHARGE; PATIENT READMISSION; PILOT PROJECTS; POLYPHARMACY; RESIDENCE CHARACTERISTICS; RISK ASSESSMENT; STATISTICS, NONPARAMETRIC; UNITED STATES;

EID: 84881301860     PISSN: 21501319     EISSN: 21501327     Source Type: Journal    
DOI: 10.1177/2150131912472905     Document Type: Article

References (23)

1. Johnell K, Klarin I. The relationship between number of drugs and potential drug-drug interactions in the elderly: a study of over 600,000 elderly patients from the Swedish Prescribed Drug Register. Drug Saf. 2007;30:911-918.
2. Hovstadius B, Hovstadius K, Astrand B, Petersson G. Increasing polypharmacy-an individual-based study of the Swedish population 2005-2008. BMC Clin Pharmacol. 2010;10:16.
3. Reason B, Terner M, Moses McKeag A, Tipper B, Webster G. The impact of polypharmacy on the health of Canadian seniors. Fam Pract. 2012;29:427-432.
4. Corsinovi L, Bo M, Ricauda Aimonino N, et al. Predictors of falls and hospitalization outcomes in elderly patients admitted to an acute geriatric unit. Arch Gerontol Geriatr. 2009;49:142-145.
5. Ziere G, Dieleman JP, Hofman A, Pols HA, van der Cammen TJ, Stricker BH. Polypharmacy and falls in the middle age and elderly population. Br J Clin Pharmacol. 2006;61:218-223.
6. Marcum ZA, Amuan ME, Hanlon JT, et al. Prevalence of unplanned hospitalizations caused by adverse drug reactions in older veterans. J Am Geriatr Soc. 2012;60:34-41.
7. Hajjar ER, Cafiero AC, Hanlon JT. Polypharmacy in elderly patients. Am J Geriatr Pharmacother. 2007;5:345-351.
8. Richardson K, Ananou A, Lafortune L, Brayne C, Matthews FE. Variation over time in the association between polypharmacy and mortality in the older population. Drugs Aging. 2011;28:547-560.
9. Alarcon T, Barcena A, Gonzalez-Montalvo JI, Penalosa C, Salgado A. Factors predictive of outcome on admission to an acute geriatric ward. Age Ageing. 1999;28:429-432.
10. Zhang Y-J, Liu W-W, Wang J-B, Guo J-J. Potentially inappropriate medication use among older adults in the USA in 2007. Age Ageing. 2011;40:398-401.
11. Frazier SC. Health outcomes and polypharmacy in elderly individuals: an integrated literature review. J Gerontol Nurs. 2005;31(9):4-11.
12. Haasum Y, Fastbom J, Johnell K. Institutionalization as a risk factor for inappropriate drug use in the elderly: a Swedish nationwide register-based study. Ann Pharmacother. 2012;46:339-346.
13. Donabedian A. The Definition of Quality and Approaches to Its Assessment. Ann Arbor, MI: Health Administration Press; 1980
14. Coleman EA, Smith JD, Raha D, Min SJ. Posthospital medication discrepancies: prevalence and contributing factors. Arch Intern Med. 2005;165:1842-1847.
15. Colla CH, Wennberg DE, Meara E, et al. Spending differences associated with the Medicare Physician Group Practice Demonstration. JAMA. 2012;308:1015-1023.
16. Fleming S. Managerial Epidemiology: Concepts and Cases. Ann Arbor, MI: Health Administration Press; 2008.
17. Tamura BK, Bell CL, Inaba M, Masaki KH. Factors associated with polypharmacy in nursing home residents. Clin Geriatr Med. 2012;28:199-216.
18. Steinman MA, Hanlon JT. Managing medications in clinically complex elders: "There's got to be a happy medium". JAMA. 2010;304:1592-1601.
19. Garrison GM, Mansukhani MP, Bohn B. Predictors of thirty-day readmission among hospitalized family medicine patients. J Am Board Fam Med. In press.
20. Silverstein MD, Qin H, Mercer SQ, Fong J, Haydar Z. Risk factors for 30-day hospital readmission in patients ≥65 years of age. Proc Bayl Univ Med Cent. 2008;21:363-372.
21. Arbaje AI, Wolff JL, Yu Q, Powe NR, Anderson GF, Boult C. Postdischarge environmental and socioeconomic factors and the likelihood of early hospital readmission among community-dwelling Medicare beneficiaries. Gerontologist. 2008;48:495-504.
22. Nobili A, Marengoni A, Tettamanti M, et al. Association between clusters of diseases and polypharmacy in hospitalized elderly patients: results from the REPOSI study. Eur J Intern Med. 2011;22:597-602.
23. Evans DC, Cook CH, Christy JM, et al. Comorbidity-polypharmacy scoring facilitates outcome prediction in older trauma patients. J Am Geriatr Soc. 2012;60:1465-1470.